Company Filing History:
Years Active: 1997-2002
Title: Ingeborg Schuster: Innovator in Pharmaceutical Chemistry
Introduction
Ingeborg Schuster is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative patents. With a total of 2 patents, her work has had a notable impact on the development of new pharmaceutical compounds.
Latest Patents
Among her latest patents are the inventions related to chromanone and thiochromanone compounds, as well as acylated aminoalkanimidazoles and triazoles. These inventions concern azole compounds of specific formulas, wherein the substituents have various significances, either in free form or salt form. The compounds can be prepared through methods such as acylation or by the opening of aziridine or oxazole rings. Importantly, these compounds can be utilized as pharmaceuticals, especially as selective inhibitors of the 25-hydroxyvitamin D3-hydroxylases. This has implications for treating disorders of proliferation and differentiation in vitamin D-responsive tissues.
Career Highlights
Ingeborg has worked with notable companies in the pharmaceutical industry, including Sandoz GmbH and Novartis AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical science.
Collaborations
In her career, Ingeborg has collaborated with esteemed colleagues such as Helmut Egger and Andreas Billich. These partnerships have fostered a collaborative environment that has enhanced her research and development efforts.
Conclusion
Ingeborg Schuster's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in the treatment of various medical conditions.